These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 15961217

  • 1. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
    Silva C, Silva J, Ribeiro MJ, Avelino A, Cruz F.
    Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
    [Abstract] [Full Text] [Related]

  • 2. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.
    Watanabe T, Yokoyama T, Sasaki K, Nozaki K, Ozawa H, Kumon H.
    Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C.
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic effect of multiple resiniferatoxin intravesical instillations in patients with refractory detrusor overactivity: a randomized, double-blind, placebo controlled study.
    Kuo HC, Liu HT, Yang WC.
    J Urol; 2006 Aug; 176(2):641-5. PubMed ID: 16813911
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
    de Sèze M, Wiart L, de Sèze MP, Soyeur L, Dosque JP, Blajezewski S, Moore N, Brochet B, Mazaux JM, Barat M, Joseph PA.
    J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial.
    Rios LA, Panhoca R, Mattos D, Srugi M, Bruschini H.
    Neurourol Urodyn; 2007 Jan; 26(6):773-8. PubMed ID: 17638305
    [Abstract] [Full Text] [Related]

  • 17. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.
    Apostolidis A, Brady CM, Yiangou Y, Davis J, Fowler CJ, Anand P.
    Urology; 2005 Feb; 65(2):400-5. PubMed ID: 15708075
    [Abstract] [Full Text] [Related]

  • 18. Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study.
    Lazzeri M, Calò G, Spinelli M, Guerrini R, Salvadori S, Beneforti P, Sandri S, Regoli D, Turini D.
    Urology; 2003 May; 61(5):946-50. PubMed ID: 12736013
    [Abstract] [Full Text] [Related]

  • 19. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.
    Amarenco G, Ismael SS, Even-Schneider A, Raibaut P, Demaille-Wlodyka S, Parratte B, Kerdraon J.
    J Urol; 2003 Jun; 169(6):2210-5. PubMed ID: 12771752
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.